Replimune Group (NASDAQ:REPL) Receives "Buy" Rating from HC Wainwright - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for IO Biotech (NASDAQ:IOBT) - MarketBeat
HC Wainwright Issues Pessimistic Forecast for SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price - MarketBeat
Scholar Rock price target raised to $40 from $35 at H.C. Wainwright - TipRanks
Phunware stock slides after downgrade to Neutral at H.C. Wainwright (PHUN:NASDAQ) - Seeking Alpha
Desktop versie